Courts / Dublin / Report

'Mystery man' who defrauded biotech company of €840k gets 3.5 years

Date
2024-12-02
Stage
Sentence
Primary locality
Dublin
County
Dublin

Summary

A 56‑year‑old man, Adrianus Johannes Kees, was sentenced to three and a half years' imprisonment after defrauding the Irish biotechnology company Ovagen of €840,000. Ovagen, seeking €28 million to patent a germ‑free egg for vaccines, was persuaded by Kees to deposit the money into an alleged escrow account in Lichtenstein. No such account existed; the funds were transferred to Kees' personal accounts and spent on a pool house, a Mercedes‑Benz lease and other expenses. Ovagen had to repay the loan taken from AIB and lost the money. Kees pleaded guilty on the fifth day of his trial, apologized to the victims, and was granted a reduced sentence after a European Arrest Warrant had led to his extradition from Spain. The court noted his lack of prior convictions and cooperation with authorities. The sentence was back‑dated to account for time already spent in custody. The unnamed 56-year-old pleaded not guilty.

Who, what, where, when and why

What: Report matter: 'Mystery man' who defrauded biotech company of €840k gets 3.5 years. Charges or matters: fraud and theft on dates between March 12, 2011 and January 10, 2012. Procedural stage: sentence

When:

Case subjects

Unnamed 56-year-old

Convicted Person

Charges: fraud and theft on dates between March 12, 2011 and January 10, 2012 (Alleged Or Contested)

Plea: Not guilty

Outcome: A 56-year-old "mystery man" who defrauded €840k from an Irish biotechnology company in the midst of an "important scientific development", making payments for a pool house and Mercedes Benz leasing, has been jailed for three and a half years.

Places mentioned

Court Venue
  • Dublin
  • Dublin Circuit Criminal Court
  • High Court
Facility
  • Cloverhill Prison

Topics

Stage Sentence

Related court reports

Read the original CNI report

Correction or retraction request

If a fact, identity, locality or legal outcome needs review, email the newsroom with this report's details prefilled.

Email a correction request